DeepMed Research

Beneficência Portuguesa De São Paulo

🇧🇷Brazil

Country: 🇧🇷Brazil

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.bpsp.org.br/site/home

Clinical Trials

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Phase 4

Completed

Conditions: Arrhythmias, Cardiac
Diabetes Mellitus

Interventions: Drug: Dapagliflozin (DAPA)

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 174

Registration Number: NCT06721442

Locations: 🇧🇷
Hospital Beneficencia Portuguesa de São Paulo, São Paulo, SP, Brazil
🇧🇷
Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil

Effectiveness of the Brazilian Diabetes Prevention Program

Not Applicable

Recruiting

Conditions: Prediabetic State
Pre Diabetes

Interventions: Behavioral: Brazilian Diabetes Prevention Program (face-to-face care)
Behavioral: Brazilian Diabetes Prevention Program (remote care)
Behavioral: Diet

First Posted Date: 2024-05-23

Last Posted Date: 2025-01-20

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 1590

Registration Number: NCT06426277

Locations: 🇧🇷
Hospital de Clínicas de Goiás - UFG, Goiânia, Goiás, Brazil
🇧🇷
Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil

Effect of a Bundle of Interventions on the Outcomes of Patients With Intracranial Devices (ICP Monitor e EVD)

Not Applicable

Not yet recruiting

Conditions: Central Nervous System Infections

Interventions: Behavioral: Health care practices and routines

First Posted Date: 2024-05-14

Last Posted Date: 2024-05-14

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 1300

Registration Number: NCT06412549

Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil

Active, not recruiting

Conditions: Central Nervous System Infections

First Posted Date: 2024-05-14

Last Posted Date: 2024-05-14

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 554

Registration Number: NCT06412523

Locations: 🇧🇷
Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brazil
🇧🇷
Hospital Geral Cleriston Andrade, Feira De Santana, BA, Brazil
🇧🇷
Unimed Vitória, Vitória, ES, Brazil

and more 15 locations

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens

Phase 4

Recruiting

Conditions: Febrile Neutropenia

Interventions: Drug: Ceftolozane-Tazobactam
Drug: Meropenem

First Posted Date: 2024-04-02

Last Posted Date: 2025-05-02

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 176

Registration Number: NCT06342115

Locations: 🇧🇷
A Beneficência Portuguesa de São Paulo, São Paulo, Brazil

Brazilian Diabetes Prevention Program: Pilot Study

Not Applicable

Completed

Conditions: Prediabetic State
PreDiabetes

Interventions: Behavioral: Brazilian Diabetes Prevention Program
Behavioral: Diet

First Posted Date: 2023-01-19

Last Posted Date: 2024-01-30

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 220

Registration Number: NCT05689658

Locations: 🇧🇷
Universidade Federal do Tocantins, Palmas, Tocantins, Brazil
🇧🇷
Hospital de Clínicas de Goiania, Goiânia, Goias, Brazil
🇧🇷
Universidade Federal de Viçosa, Viçosa, Minas Gerais, Brazil

and more 2 locations

QOL of Women With HR-Positive Metastatic BC Treated in the First-line Setting: Comparison Between Public and Private Institutions.

Conditions: Quality of Life
Breast Neoplasm Female

Interventions: Other: Quality of Life

First Posted Date: 2022-03-18

Last Posted Date: 2022-03-18

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 202

Registration Number: NCT05287139

Locations: 🇧🇷
Hospital Pérola Byington, São Paulo, Brazil

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

Not Applicable

Recruiting

Conditions: Breast Neoplasm Female
Quality of Life

Interventions: Device: Use of the WeCancer app combined with the smartwatch.

First Posted Date: 2022-03-14

Last Posted Date: 2024-08-26

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 68

Registration Number: NCT05277935

Locations: 🇧🇷
Oncoclínicas, Rio De Janeiro, Brazil
🇧🇷
A Beneficência Portuguesa de São Paulo, São Paulo, Brazil
🇧🇷
A.C.Camargo Cancer Center, São Paulo, Brazil

and more 1 locations

Increasing Amyloidosis Awareness and Diagnosis Through Programmatic Imaging, Blood/Urine Testing and Pathology

Conditions: Amyloidosis

First Posted Date: 2021-07-30

Last Posted Date: 2021-12-29

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 100

Registration Number: NCT04983433

Locations: 🇧🇷
Gisele Medeiros Bastos, São Paulo, SP, Brazil

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Phase 3

Terminated

Conditions: Cytokine Release Syndrome
COVID
SARS Pneumonia

Interventions: Drug: Tocilizumab

First Posted Date: 2020-05-27

Last Posted Date: 2020-08-26

Lead Sponsor: Beneficência Portuguesa de São Paulo

Target Recruit Count: 129

Registration Number: NCT04403685

Locations: 🇧🇷
HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil
🇧🇷
Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil
🇧🇷
UNIFESP, São Paulo, Sao Paulo, Brazil

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy